CV Sciences, Inc. reported revenue of $4.0 million for the second quarter of 2024. This figure represents the company's sales performance during the period ending June 30, 2024.
The company recorded an Adjusted EBITDA loss of $6,000 for the second quarter of 2024. This metric indicates the company's operational profitability before non-cash expenses and other adjustments.
These financial results provide investors with an update on the company's revenue generation and its progress towards profitability, offering a snapshot of its performance in a competitive market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.